Seeing Clearly: A Visual Guide to Diagnosing Prurigo Nodularis in Skin of Color: An Online Activity

Join Dr. Shahriari and Dr. Taylor as they discuss the heterogeneous clinical features of prurigo nodularis and how the presentation can differ in skin of color. This engaging 30-minute Satellite Symposium from the Winter Clinical Miami conference highlights case-based insights on diagnosing prurigo nodularis and the latest on new and emerging targeted therapies.

“Historically we used topicals, intralesional steroids, some immunosuppressants, neuromodulators. But the reality was we were getting partial responses, and we had a safety trade-off… Now in the year 2026, we actually have two FDA-approved therapies that are really changing the game for our patients with prurigo nodularis.” - Mona Shahriari, MD

Seeing Clearly: A Visual Guide to Diagnosing Prurigo Nodularis in Skin of Color: An Online Activity

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.